Interpace Biosciences, Inc. financial data

Symbol
IDXG on OTC
Location
Waterview Plaza, Suite 310, 2001 Route 46, Parsippany, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
Interpace Diagnostics Group, Inc. (to 11/1/2019), PDI INC (to 12/22/2015), PROFESSIONAL DETAILING INC (to 11/13/2002)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 61 % -31.6%
Quick Ratio 6.94 % -18.6%
Debt-to-equity -45.3 % +10.6%
Return On Equity -4.59 % -119%
Return On Assets 21.4 %
Operating Margin -63.7 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.39M shares +1.86%
Common Stock, Shares, Outstanding 4.38M shares +1.51%
Entity Public Float 3.79M USD -67.3%
Common Stock, Value, Issued 406K USD +0.25%
Weighted Average Number of Shares Outstanding, Basic 4.38M shares +1.51%
Weighted Average Number of Shares Outstanding, Diluted 4.4M shares +1.97%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 5.68M USD
Revenue from Contract with Customer, Excluding Assessed Tax 41.7M USD +11.5%
Cost of Revenue 17.1M USD +15.3%
Research and Development Expense 584K USD -3.15%
Selling and Marketing Expense 11M USD +17.9%
General and Administrative Expense 8.36M USD -20.4%
Operating Income (Loss) 4.43M USD +467%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3.01M USD +436%
Income Tax Expense (Benefit) 17K USD +467%
Net Income (Loss) Attributable to Parent 2.81M USD +1078%
Earnings Per Share, Basic 0.65 USD/shares +1075%
Earnings Per Share, Diluted 0.64 USD/shares +1075%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.02M USD -60.2%
Accounts Receivable, after Allowance for Credit Loss, Current 6.21M USD +12.2%
Inventory, Net 1.23M USD +4.59%
Other Assets, Current 1.94M USD -18%
Assets, Current 10.2M USD -21.6%
Property, Plant and Equipment, Net 1.13M USD +85.8%
Operating Lease, Right-of-Use Asset 1.64M USD -21.8%
Goodwill 8.43M USD 0%
Other Assets, Noncurrent 45K USD 0%
Assets 13M USD -18.6%
Accounts Payable, Current 1.76M USD +4.26%
Employee-related Liabilities, Current 1.24M USD +10.3%
Liabilities, Current 19M USD +40.3%
Long-term Debt and Lease Obligation 1.75M USD -41.1%
Operating Lease, Liability, Noncurrent 1.29M USD -21.9%
Other Liabilities, Noncurrent 5.15M USD +5.82%
Liabilities 25.5M USD -19.5%
Retained Earnings (Accumulated Deficit) -246M USD +1.13%
Stockholders' Equity Attributable to Parent -59M USD +5.11%
Liabilities and Equity 13M USD -18.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -58K USD -105%
Net Cash Provided by (Used in) Financing Activities -600K USD -100%
Net Cash Provided by (Used in) Investing Activities -28K USD +56.9%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 4.49M shares +2.19%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -686K USD -189%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.02M USD -60.2%
Deferred Tax Assets, Valuation Allowance 38.7M USD +1.04%
Operating Lease, Liability 1.61M USD -23.2%
Payments to Acquire Property, Plant, and Equipment 28K USD -56.9%
Lessee, Operating Lease, Liability, to be Paid 2.04M USD -25.9%
Property, Plant and Equipment, Gross 3.33M USD +16.6%
Operating Lease, Liability, Current 319K USD -28%
Lessee, Operating Lease, Liability, to be Paid, Year Two 500K USD +11.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 450K USD -21.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 438K USD -34.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 550K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 26.4M USD -1.06%
Unrecognized Tax Benefits 877K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 275K USD -66.7%
Amortization of Intangible Assets 900K USD -30.8%
Depreciation, Depletion and Amortization 356K USD -54.4%
Deferred Tax Assets, Net of Valuation Allowance 21K USD -96.8%
Share-based Payment Arrangement, Expense 413K USD -55.7%